Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 More on atypical fractures of the femoral diaphysis.

× No keyword cloud information.

15 in total

1. "Fatigue" having a role in the pathogenesis of osteonecrosis of the jaws.

Authors: Athanassios Kyrgidis; Konstantinos Vahtsevanos
Journal: Clin Oral Investig Date: 2009-08-13 Impact factor: 3.573

Review 2. Adverse effects of bisphosphonates: implications for osteoporosis management.

Authors: Kurt A Kennel; Matthew T Drake
Journal: Mayo Clin Proc Date: 2009-07 Impact factor: 7.616

Review 3. Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?

Authors: M H Edwards; F C McCrae; S A Young-Min
Journal: Osteoporos Int Date: 2009-06-27 Impact factor: 4.507

4. Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.

Authors: Joseph L Shaker
Journal: Ther Adv Musculoskelet Dis Date: 2009-04 Impact factor: 5.346

5. Radiographic features of multifocal endosteal thickening of the femur in patients on long-term bisphosphonate therapy.

Authors: P Chandra Mohan; Tet Sen Howe; Joyce S B Koh; Meng Ai Png
Journal: Eur Radiol Date: 2012-07-20 Impact factor: 5.315

6. Atypical femoral diaphyseal and subtrochanteric fractures and their association with bisphosphonates.

Authors: Frankie Leung; Tak-Wing Lau; Michael To; Keith Dip-Kei Luk; Annie Wai Chee Kung
Journal: BMJ Case Rep Date: 2009-03-05

7. Bisphosphonate remains highly localized after elution from porous implants.

Authors: Kimberly McKenzie; J Dennis Bobyn; Jacintha Roberts; Dorota Karabasz; Michael Tanzer
Journal: Clin Orthop Relat Res Date: 2011-02 Impact factor: 4.176

8. Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate.

Authors: Jörg Schilcher; Per Aspenberg
Journal: Acta Orthop Date: 2009-08 Impact factor: 3.717

9. Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies.

Authors: P D Miller; R R Recker; S Harris; S Silverman; D Felsenberg; J Reginster; B-M Day; C Barr; D Masanauskaite
Journal: Osteoporos Int Date: 2013-10-18 Impact factor: 4.507

10. Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study.

Authors: Juan Erviti; Alvaro Alonso; Belén Oliva; Javier Gorricho; Antonio López; Julia Timoner; Consuelo Huerta; Miguel Gil; Francisco De Abajo
Journal: BMJ Open Date: 2013-01-30 Impact factor: 2.692